Concepedia

Maria da Penha Ananias Morita

MD

Statistics

Publications

9

Citations

326

H-Index

9

Active since

1993

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Faculdade de Medicina de São José do Rio Preto

Fondazione IRCCS Istituto Neurologico Carlo Besta

Maria da Penha Ananias Morita is an author at Alexion Pharmaceuticals (United States) specializing in medicine, myasthenia gravis, and neurology.

ORCID

Publications per year

1993–2021

9

Publications

9

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

, , +9

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Henning Andersen, Renato Mantegazza, Jing Jing Wang et al. · Quality of Life Research · 2019 · 56 citations · Full text

, , +14

Body mass index and carpal tunnel syndrome

João Aris Kouyoumdjian, Maria da Penha Ananias Morita, PAULO RICARDO FERNANDO ROCHA et al. · Arquivos de Neuro-Psiquiatria · 2000 · 44 citations · Full text

, , +14

Fatal rhabdomyolysis after acute sodium monensin (Rumensin®) toxicity: case report

João Aris Kouyoumdjian, Maria da Penha Ananias Morita, Adriana Komatsu Sato et al. · Arquivos de Neuro-Psiquiatria · 2001 · 42 citations · Full text

, , +14

Congenital myasthenic syndrome: Correlation between clinical features and molecular diagnosis

Eduardo de Paula Estephan, Antônio Alberto Zambon, Rachel Thompson et al. · European Journal of Neurology · 2021 · 26 citations

, , +15

1–5 of 9